Determining the Prognostic Value of Identifying Genetic Mutations in Dogs with Lymphoma
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.
Displaying 43 - 49 of 69 Results
Measuring Chemotherapy Drug Resistance in Dogs with T-cell Lymphoma
Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.
Targeting a Genetic Mutation Associated with Canine Bladder Cancer
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Predicting Chemotherapy Drug Response for Dogs with Bone Cancer
Researchers will assess how well specific chemotherapy drugs work as an adjunct therapy for dogs recovering from bone cancer surgery.
Investigating a New Treatment for Oral Cancers
Researchers will investigate a new treatment for feline oral cancers, using small molecular inhibitors.
Improving Diagnostic Tools for Classifying Soft-Tissue Sarcomas in Cats
Researchers will develop advanced DNA-based techniques for characterizing feline soft-tissue sarcomas, which may help veterinarians provide a more comprehensive diagnosis and improve their ability to choose the most appropriate clinical management strategies for these cancers.
Looking for New Targeted Therapies for Osteosarcoma
Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.